B Cell Depletion: Rituximab in Glomerular Disease and Transplantation
B cells play a central role in the pathogenesis of many autoimmune diseases. Selective targeting can be achieved with the use of the monoclonal antibody rituximab. In addition to being a drug for non-Hodgkin's lymphoma, rituximab is also an FDA-approved treatment for refractory rheumatoid arthr...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2013-12-01
|
| Series: | Nephron Extra |
| Subjects: | |
| Online Access: | http://www.karger.com/Article/FullText/356050 |